<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="131008">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01755377</url>
  </required_header>
  <id_info>
    <org_study_id>BIOMARCHA</org_study_id>
    <nct_id>NCT01755377</nct_id>
  </id_info>
  <brief_title>New Tools for the Diagnosis, Prognosis and Treatment Follow-up in Chagas Disease</brief_title>
  <acronym>BIOMARCHA</acronym>
  <official_title>Evolution of Serologic Biomarkers and Diastolic Function and Segmentary Contractility Determined by Echocardiography After Treatment in Chagas Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Barcelona Centre for International Health Research</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Barcelona Centre for International Health Research</source>
  <oversight_info>
    <authority>Spain: Agencia Española de Medicamentos y Productos Sanitarios</authority>
    <authority>Spain: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chagas disease is endemic to Latin America, and is of emerging importance in non-endemic
      countries because migration of people infected with T. cruzi. Current methods for diagnosis
      of T. cruzi infection are not ideal. Existing drugs for treatment are very limited, produce
      severe side-effects, and their effectiveness cannot be properly evaluated. Reliable
      biomarkers for prognosis, early diagnosis and effectiveness of treatment will be
      investigated.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Biomarkers for prognosis, early diagnosis and effectiveness of treatment.</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Conventional polymerase chain reaction of T. cruzi in blood
Measurement of Brain natriuretic factor
Measurement of Prothrombotic factors
Measurement of antibodies against specific proteins of the trypomastigote of T. cruzi
Investigation of the phylogenetics of the parasite and the role of the lineages of T.cruzi in the clinical presentation and disease's progression</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiac function after antiparasitic treatment</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>- Correlation between biomarkers and alterations of the left ventricle diastolic function and segmentary contractility after antiparasitic treatment</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">63</enrollment>
  <condition>Chagas Disease</condition>
  <arm_group>
    <arm_group_label>No Chagas Disease</arm_group_label>
    <description>Participants with no Chagas Disease will be evaluated as a Control Group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Chagas Disease</arm_group_label>
    <description>Participants diagnosed with Chagas Disease will be followed-up as a Case Group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Benznidazole</intervention_name>
    <arm_group_label>Chagas Disease</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Migrants from Latin America visiting the Tropical Medicin Clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients from endemic areas (Latin America)

          -  Older than 18 years old and younger than 50

          -  With serological confirmation of Chagas Disease infection with two different
             techniques

          -  Indeterminate or initial cardiac form

          -  No previously treated for Chagas Disease

        Exclusion Criteria:

          -  Co-morbidity: previous cardiac disease from other aetiology (ischemic, alcoholic or
             hypertensive), active inflammatory or immunology diseases for another agent. Hepatic
             disfunction

          -  Pregnancy or lactation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joaquim Gascón, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Barcelona Centre for International Health Research (CRESIB)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Edelweiss Aldasoro, MD</last_name>
    <phone>+34 932 275 706</phone>
    <phone_ext>2182</phone_ext>
    <email>aldasoro@clinic.ub.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joaquim Gascón, PhD</last_name>
    <phone>+34 932 275 706</phone>
    <phone_ext>3288</phone_ext>
    <email>jgascon@clinic.ub.es</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>International Health Department, Hospital Clinic, Barcelona</name>
      <address>
        <city>Barcelona</city>
        <state>Cataluña</state>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edelweiss Aldasoro, MD</last_name>
      <phone>+34 932 275 706</phone>
      <phone_ext>2182</phone_ext>
      <email>aldasoro@clinic.ub.es</email>
    </contact>
    <contact_backup>
      <last_name>Joaquim Gascón, PhD</last_name>
      <phone>+34 932 275 706</phone>
      <phone_ext>3288</phone_ext>
      <email>jgascon@clinic.ub.es</email>
    </contact_backup>
    <investigator>
      <last_name>Edelweiss Aldasoro, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elizabeth Posada</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joaquim Gascón, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana Garcia, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ander Regueiro, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mª Carmen Thomas, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jaime Hernández, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Manuel Carlos López, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miriam Álvarez, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 8, 2013</lastchanged_date>
  <firstreceived_date>December 19, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Chagas Disease</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Benzonidazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
